Andrew Miller
2019 - Karuna Therapeutics
In 2019, Andrew Miller earned a total compensation of $1.4M as Chief Operating Officer at Karuna Therapeutics, a 152% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $348,024 |
|---|---|
| Option Awards | $698,426 |
| Salary | $392,392 |
| Other | $8,400 |
| Total | $1,447,242 |
Miller received $698.4K in option awards, accounting for 48% of the total pay in 2019.
Miller also received $348K in non-equity incentive plan, $392.4K in salary and $8.4K in other compensation.
Rankings
In 2019, Andrew Miller's compensation ranked 7,478th out of 13,971 executives tracked by ExecPay. In other words, Miller earned more than 46.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,478 out of 13,971 | 47th |
Division Manufacturing | 2,900 out of 5,701 | 49th |
Major group Chemicals And Allied Products | 1,090 out of 2,200 | 51st |
Industry group Drugs | 928 out of 1,886 | 51st |
Industry Pharmaceutical Preparations | 685 out of 1,398 | 51st |
Source: SEC filing on April 29, 2020.
Miller's colleagues
We found three more compensation records of executives who worked with Andrew Miller at Karuna Therapeutics in 2019.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
PTC CEO James Heppelmann's 2018 pay jumps 357% to $50M
January 23, 2019